Mizuho lowered the firm’s price target on GE HealthCare (GEHC) to $95 from $110 and keeps an Outperform rating on the shares as part of a Q1 preview for the medical devices and diagnostics group. The firm views tariffs, China exposure, and the latest procedure outlook as the key themes heading into the quarter. It cut numbers preemptively.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare price target lowered to $95 from $103 at BTIG
- Hold Rating for GE Healthcare Technologies Inc. Amid US-China Trade Tensions and Global Recession Concerns
- China starts anti-dumping probe of imported medical CT tubes, Global Times says
- GE HealthCare, FPT announce strategic cooperation agreement
- GE Healthcare’s New $3.5 Billion Credit Agreements